Truist Cuts Veeva (VEEV) PT Following Strong Q4 Results

Truist Cuts Veeva (VEEV) PT Following Strong Q4 Results
Truist Cuts Veeva (VEEV) PT Following Strong Q4 Results

Veeva Systems Inc. (NYSE:VEEV) is on our list of 10 Best Large Cap Growth Stocks to Buy.

Truist Cuts Veeva (VEEV) PT Following Strong Q4 Results

On March 5, 2026, Veeva Systems Inc.’s (NYSE:VEEV) strong fourth-quarter results and better-than-expected billings caught Truist’s attention. While the firm lowered its price target on Veeva Systems Inc. (NYSE:VEEV) to $262 from $275, it reiterated a Buy rating. The firm highlighted Veeva Systems Inc. (NYSE:VEEV) guidance that topped consensus estimates, indicating continued business momentum. Truist added that the company’s revised outlook reflects clients’ planning cycles rather than expectations of major macroeconomic improvements. This reflects Veeva Systems Inc.’s (NYSE:VEEV) relatively cautious approach to guidance, according to the company, despite improving macroeconomic visibility across several sectors. Furthermore, this view was supported on the same day that TD Cowen updated its model in response to the company’s impressive quarterly results. The company lowered its price target for Veeva Systems Inc. (NYSE:VEEV) from $380 to $300, but maintained a Buy rating on the stock. The firm said that because Veeva Systems Inc.’s (NYSE:VEEV) platform is integrated, it offers a significant competitive advantage over new AI-native point solution rivals, and TD Cowen is no longer overly concerned about the risks associated with artificial intelligence. With management guidance reinforcing the bullish analyst outlook, overall analyst sentiment remains positive as of March 6, 2026. The consensus price target of $195.49 implies an upside potential of approximately 40.67%, representing a bullish stance of over 70% of the analysts covering it. Meanwhile, over the past six months, the stock has fallen more than 28% amid a roughly 40% decline in the Health Information Services sector. Veeva Systems Inc. (NYSE:VEEV) provides cloud software for life sciences companies, including data management, CRM, and regulated content solutions to drive productivity and compliance. While we recognize VEEV’s potential as an investment, we believe certain AI stocks offer greater growth potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that’s also benefiting significantly from Trump-era tariffs and the offshoring trend, check out our free report on best short-term AI stock. READ NEXT: 33 stocks that should double in 3 years and 15 stocks that will make you rich in 10 years. Disclosure: None. Follow Insider Monkey on Google News.

Source link